RTA Laboratuvarlari Biyolojik (RTALB) — Cash Flow Reinvestment Rate

Latest as of June 2025: 5.26x

RTA Laboratuvarlari Biyolojik (RTALB) has a Cash Flow Reinvestment Rate of 5.26x as of June 2025, reinvesting TL110.45 Million (capex TL2.68 Million plus investments TL107.77 Million) from operating cash flow of TL20.98 Million. Check RTALB cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

5.26x
(Capex + Investments) / Operating CF

Total Reinvested

TL110.45 Million
Capex + Investments

Operating Cash Flow

TL20.98 Million
TRY

Capital Expenditures

TL2.68 Million
TRY

RTA Laboratuvarlari Biyolojik Cash Flow Reinvestment Rate (2010–2023)

Historical reinvestment intensity for RTA Laboratuvarlari Biyolojik across 12 annual periods. Explore investment intensity of RTA Laboratuvarlari Biyolojik to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for RTA Laboratuvarlari Biyolojik (2010–2023)

Year-by-year capital reinvestment analysis for RTA Laboratuvarlari Biyolojik. For live market cap and broader valuation context, see RTALB market cap overview.

Year Reinvestment Rate Total Reinvested (TRY) Operating CF Capex YoY Change
2023 1.33x TL96.46 Million TL72.41 Million TL48.48 Million ▲ +251.9%
2021 0.38x TL26.04 Million TL68.78 Million TL21.43 Million ▼ -78.7%
2020 1.78x TL16.65 Million TL9.37 Million TL15.96 Million ▼ -78.4%
2019 8.21x TL29.36 Million TL3.58 Million TL5.19 Million ▼ -52.9%
2017 17.43x TL24.49 Million TL1.41 Million TL318.64K ▲ +853.4%
2016 1.83x TL5.23 Million TL2.86 Million TL2.42 Million ▲ +576.1%
2015 0.27x TL1.67 Million TL6.18 Million TL1.67 Million ▲ +9.1%
2014 0.25x TL640.00K TL2.58 Million TL640.00K ▼ -70.8%
2013 0.85x TL9.56 Million TL11.26 Million TL9.56 Million ▼ -9.3%
2012 0.94x TL2.09 Million TL2.24 Million TL2.09 Million ▲ +349.9%
2011 0.21x TL335.00K TL1.61 Million TL335.00K ▲ +6.7%
2010 0.19x TL541.00K TL2.78 Million TL541.00K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow